The Company’s Board of Directors resolved to convene the 2022 Annual General Shareholders’ Meeting

1.Date of the board of directors resolution:2022/03/18
2.General shareholders’ meeting date:2022/06/27
3.General shareholders’ meeting location:Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Da’ an Dist., Taipei City, Taiwan)
4.Shareholders meeting will be held by means of (physical shareholders meeting/ visual communication assisted shareholders meeting / visual communication shareholders meeting):Physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1) 2021 Business Report
(2) 2021 Audit Committee’s Review Report
(3) Status of the Sound Operating Plan of the Company
6.Cause for convening the meeting II.Acknowledged matters:
(1) 2021 Annual Final Accounting Ledgers and Statements
(2) 2021 Earnings Distribution Loss Off-setting
7.Cause for convening the meeting III.Matters for Discussion:
(1) Amendment of the Company’s “Articles of Incorporation”
(2) Amendment of the Company’s “Procedures for Asset Acquisition & Disposal”
8.Cause for convening the meeting IV.Election matters:
(1) Election of 7th Board of Directors
9.Cause for convening the meeting V.Other Proposals:
(1) Remove the restriction of Competition Prohibition
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/04/29
12.Book closure ending date:2022/06/27
13.Any other matters that need to be specified:
Pursuant to Article 172-1 of the Company Act, the Annual General Meeting will accept proposals by shareholders holding more than 1% of shares from 2022/04/18 to 2022/04/28. Shareholders shall submit the proposal with applicable contact information before 5:00 pm on 2022/4/28 for the Board of Directors to review and respond. (Please mark the letter “Proposal for Annual General Meeting “ and send it by priority mail). Overdue will not be accepted.
Proposal receiving office is the Financial Department of OBI Pharma Inc. (Address: 7F., No. 369, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City, Taiwan, Tel: 02-27866589, ext. 115/157). The shareholders will be able to exercise their voting rights electronically from 2022/05/28 to 2022/06/24. The electronic voting system is managed by Taiwan Depository and Clearing Corporation at https://www.stockvote.com.tw